Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculation
Abstract We previously reported that mice immunized twice with a lipid nanoparticle vaccine comprising four monkeypox viral mRNAs raised neutralizing antibodies and antigen-specific T cells and were protected against a lethal intranasal challenge with vaccinia virus (VACV). Here we demonstrated that...
Saved in:
| Main Authors: | Catherine A. Cotter, Maxinne A. Ignacio, Jeffrey L. Americo, Patricia L. Earl, Eric M. Mucker, Tiffany R. Frey, Andrea Carfi, Jay W. Hooper, Alec W. Freyn, Bernard Moss |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-12-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-024-01052-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multivalent mpox protein nanoparticle vaccines confer cross-protection against orthopoxvirus infection
by: Lijun Zhang, et al.
Published: (2025-08-01) -
Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic
by: Stephen M. Laidlaw, et al.
Published: (2025-04-01) -
A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques
by: Fengwen Xu, et al.
Published: (2025-07-01) -
Mpox multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primates
by: Ahmed A. Belghith, et al.
Published: (2025-05-01) -
Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates
by: Leonie Mayer, et al.
Published: (2024-11-01)